IKK-ε coordinates invasion and metastasis of ovarian cancer

Cancer Research

Volumn 72, Issue 21, 2012, Pages 5494-5504

  Hsu, Sarah ^a   Kim, Marianne ^a   Hernandez, Lidia ^a   Grajales, Valentina ^a   Noonan, Anne ^a   Anver, Miriam ^b   Davidson, Ben ^c   Annunziata, Christina M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

I KAPPA B KINASE ALPHA; I KAPPA B KINASE BETA; I KAPPA B KINASE EPSILON; SHORT HAIRPIN RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CELL ADHESION, CELL AGGLUTINATION AND CELL AGGREGATION; CELL MOTILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; OUTCOME ASSESSMENT; OVARY CANCER; OVARY METASTASIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION;

ANIMALS; BLOTTING, WESTERN; CELL LINE, TUMOR; FEMALE; HUMANS; I-KAPPA B KINASE; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, GLANDULAR AND EPITHELIAL; OVARIAN NEOPLASMS; SIGNAL TRANSDUCTION; TISSUE ARRAY ANALYSIS; TRANSCRIPTOME; TRANSPLANTATION, HETEROLOGOUS;

EID: 84868217069     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-11-3993     Document Type: Article

References (29)

1. Pignata S, Cannella L, Leopardo D, Pisano C, Bruni GS, Facchini G. Chemotherapy in epithelial ovarian cancer. Cancer Lett 2011;303: 73-83.
2. Annunziata CM, Azad N, Dhamoon AS, Whiteley G, Kohn EC Ovarian cancer in the proteomics era. Int J Gynecol Cancer 2008; 18 Suppl 1:1-6.
3. Martin LP, Schilder RJ. Management of recurrent ovarian car-cinoma: current status and future directions. Semin Oncol 2009; 36:112-25.
4. Bonome T, Levine DA, Shih J, Randonovich M, Pise-Masison CA, Bogomolniy F, et al. A gene signature predicting for survival in sub-optimally debulked patientswith ovarian cancer. Cancer Res 2008;68: 5478-86.
5. TCGA. Integrated genomic analyses of ovarian carcinoma. Nature 2011;474:609-15.
6. Luo JL, Tan W, Ricono JM, Korchynskyi O, Zhang M, Gonias SL, et al. Nuclear cytokine-activated IKKalpha controls prostate cancer metastasis by repressing Maspin. Nature 2007;446: 690-4.
7. Annunziata CM, Stavnes HT, Kleinberg L, Berner A, Hernandez LF, Birrer MJ, et al. Nuclear factor kappa B transcription factors are coex-pressed and convey a poor outcome in ovarian cancer. Cancer 2010;116:3276-84.
8. Hernandez L, Hsu SC, Davidson B, Birrer MJ, Kohn EC, Annunziata CM. Activation of NF-kappa B signaling by inhibitor of NF-kappa B kinase beta increases aggressiveness of ovarian cancer. Cancer Res 2010;70:4005-14.
9. Boehm JS, Zhao JJ, Yao J, Kim SY, Firestein R, Dunn IF, et al. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007;129:1065-79.
10. Hutti JE, Shen RR, Abbott DW, Zhou AY, Sprott KM, Asara JM, et al. Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation. Mol Cell 2009; 34:461-72.
11. Guo JP, Shu SK, He L, Lee YC, Kruk PA, Grenman S, et al. Deregulation of IKBKE is associated with tumor progression, poor prognosis, and cisplatin resistance in ovarian cancer. Am J Pathol 2009;175:324-33.
12. The American Type Culture Collection (ATCC). Available from: http:// www.atcc.org/Culturesand Products/Cell Biology/STRProfile Database/ tabid/174/Default.aspx
13. The Cell Line Integrated Molecular Authentication (CLIMA). Available from: http://bioinformatics.istge.it/clima/
14. Lorenzi PL, Reinhold WC, Varma S, Hutchinson AA, Pommier Y, Chanock SJ, et al. DNA fingerprinting of the NCI-60 cell line panel. Mol Cancer Ther2009;8:713-24.
15. GSE9899. Available from: http://www.ncbi.nlm.nih.gov/gds?term= GSE9899
16. The Cancer Genome Atlas (TCGA). Available from: http://cancer genome.nih.gov/cancersselected/ovarian
17. Tothill RW, Tinker AV, George J, Brown R, Fox SB, Lade S, et al. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clin Cancer Res 2008;14:5198-208.
18. Koenen HJ, Smit MJ, Simmelink MM, Schuurman B, Beelen RH, Meijer S. Effect of intraperitoneal administration of granulocyte/macrophage-colony- stimulating factor in rats on omental milky-spot composition and tumoricidal activity in vivo and in vitro. Cancer Immunol Immun-other 1996;42:310-6.
19. Yokoyama Y, Hirakawa H, Wang H, Mizunuma H. Is omentec-tomy mandatory in the operation for ovarian cancer? Preliminary results in a rat study. Eur J Obstet Gynecol Reprod Biol 2012; 164:89-92.
20. Devoogdt N, Rasool N, Hoskins E, Simpkins F, Tchabo N, Kohn EC Overexpression of protease inhibitor-dead secretory leukocyte pro-tease inhibitor causes more aggressive ovarian cancer in vitro and in vivo. Cancer Sci 2009;100:434-40.
21. Tang SW, Yang TC, Lin WC, Chang WH, Wang CC, Lai MK, et al. Nicotinamide N-methyltransferase induces cellular invasion through activating matrix metalloproteinase-2 expression in clearcell renal cel carcinoma cells. Carcinogenesis 2011;32:138-45.
22. Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D. Over-lappinggeneexpressionprofilesofcellmigrationandtumorinvasionin humanbladdercanceridentifymetallothionein 1 Eandnicotinamide N-methyltransferase as novel regulators of cell migration. Oncogene 2008;27:6679-89.
23. Soikkeli J, Podlasz P, Yin M, Nummela P, Jahkola T, Virolainen S, et al. Metastatic outgrowth encompasses COL-I, FN1, and POSTN up-regulation and assembly to fibrillar networks regulat-ing cell adhesion, migration, and growth. Am J Pathol 2010;177: 387-403.
24. Kim H, Watkinson J, Varadan V, Anastassiou D. Multi-cancer compu-tational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1. BMC Med Genomics 2010;3:51.
25. Bignotti E, Tassi RA, Calza S, Ravaggi A, Bandiera E, Rossi E, et al. Gene expression profile of ovarian serous papillary carcinomas: identification of metastasis-associated genes. Am J Obstet Gynecol 2007;196:e241-211.
26. Mc Fadyen MC, Cruickshank ME, Miller ID, Mc Leod HL, Melvin WT, Haites NE, et al. Cytochrome P450 CYP1B1 over-expression in primary and metastatic ovarian cancer. Br J Cancer 2001;85: 242-6.
27. Nielsen HL, Ronnov-Jessen L, Villadsen R, Petersen OW. Identifi-cation of EPSTI1, a novel gene induced by epithelial-stromal interaction in human breast cancer. Genomics 2002;79:703-10.
28. Gyrd-Hansen M, Meier P. IAPs:fromcaspaseinhibitorstomodulators of NF-kappa B, inflammation and cancer. Nat Rev Cancer 2010;10: 561-74.
29. Vince JE, Wong WW, Khan N, Feltham R, Chau D, Ahmed AU, et al. IAP antagonists target c IAP1 to induce TNFalpha-dependent apoptosis. Cell 2007;131:682-93.